0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Antifungal Treatment - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: September 2024
|
Report Code: QYRE-Auto-25K6940
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Antifungal Treatment Market Insights and Forecast to 2028
BUY CHAPTERS

Antifungal Treatment - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-25K6940
Report
September 2024
Pages:85
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Antifungal Treatment - Market Size

The global market for Antifungal Treatment was estimated to be worth US$ 14770 million in 2023 and is forecast to a readjusted size of US$ 18240 million by 2030 with a CAGR of 2.6% during the forecast period 2024-2030

Antifungal Treatment - Market

Antifungal Treatment - Market

An antifungal medication, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis (thrush), serious systemic infections such as cryptococcal meningitis, and others.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Antifungal Treatment, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Antifungal Treatment by region & country, by Type, and by Application.
The Antifungal Treatment market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antifungal Treatment.
Market Segmentation

Scope of Antifungal Treatment - Market Report

Report Metric Details
Report Name Antifungal Treatment - Market
Forecasted market size in 2030 US$ 18240 million
CAGR 2.6%
Forecasted years 2024 - 2030
Segment by Type:
Segment by Application
  • Dermatophytosis
  • Aspergillosis
  • Candidiasis
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Novartis, Pfizer, Sanofi-Aventis, Merck&Co, Enzon Pharmaceuticals, Bayer AG, Astellas Pharma, GlaxoSmithKline, Abbott
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Antifungal Treatment manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Revenue of Antifungal Treatment in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Revenue of Antifungal Treatment in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Antifungal Treatment - Market size in 2030?

Ans: The Antifungal Treatment - Market size in 2030 will be US$ 18240 million.

Who are the main players in the Antifungal Treatment - Market report?

Ans: The main players in the Antifungal Treatment - Market are Novartis, Pfizer, Sanofi-Aventis, Merck&Co, Enzon Pharmaceuticals, Bayer AG, Astellas Pharma, GlaxoSmithKline, Abbott

What are the Application segmentation covered in the Antifungal Treatment - Market report?

Ans: The Applications covered in the Antifungal Treatment - Market report are Dermatophytosis, Aspergillosis, Candidiasis, Other

What are the Type segmentation covered in the Antifungal Treatment - Market report?

Ans: The Types covered in the Antifungal Treatment - Market report are Azoles, Echinocandins, Polyenes, Allyamines, Other

Recommended Reports

Antifungal Treatments

Infectious Disease Therapy

Topical and Organ-specific Treatments

1 Market Overview
1.1 Antifungal Treatment Product Introduction
1.2 Global Antifungal Treatment Market Size Forecast
1.3 Antifungal Treatment Market Trends & Drivers
1.3.1 Antifungal Treatment Industry Trends
1.3.2 Antifungal Treatment Market Drivers & Opportunity
1.3.3 Antifungal Treatment Market Challenges
1.3.4 Antifungal Treatment Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Antifungal Treatment Players Revenue Ranking (2023)
2.2 Global Antifungal Treatment Revenue by Company (2019-2024)
2.3 Key Companies Antifungal Treatment Manufacturing Base Distribution and Headquarters
2.4 Key Companies Antifungal Treatment Product Offered
2.5 Key Companies Time to Begin Mass Production of Antifungal Treatment
2.6 Antifungal Treatment Market Competitive Analysis
2.6.1 Antifungal Treatment Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Antifungal Treatment Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antifungal Treatment as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Azoles
3.1.2 Echinocandins
3.1.3 Polyenes
3.1.4 Allyamines
3.1.5 Other
3.2 Global Antifungal Treatment Sales Value by Type
3.2.1 Global Antifungal Treatment Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Antifungal Treatment Sales Value, by Type (2019-2030)
3.2.3 Global Antifungal Treatment Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Dermatophytosis
4.1.2 Aspergillosis
4.1.3 Candidiasis
4.1.4 Other
4.2 Global Antifungal Treatment Sales Value by Application
4.2.1 Global Antifungal Treatment Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Antifungal Treatment Sales Value, by Application (2019-2030)
4.2.3 Global Antifungal Treatment Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Antifungal Treatment Sales Value by Region
5.1.1 Global Antifungal Treatment Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Antifungal Treatment Sales Value by Region (2019-2024)
5.1.3 Global Antifungal Treatment Sales Value by Region (2025-2030)
5.1.4 Global Antifungal Treatment Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Antifungal Treatment Sales Value, 2019-2030
5.2.2 North America Antifungal Treatment Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Antifungal Treatment Sales Value, 2019-2030
5.3.2 Europe Antifungal Treatment Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Antifungal Treatment Sales Value, 2019-2030
5.4.2 Asia Pacific Antifungal Treatment Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Antifungal Treatment Sales Value, 2019-2030
5.5.2 South America Antifungal Treatment Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Antifungal Treatment Sales Value, 2019-2030
5.6.2 Middle East & Africa Antifungal Treatment Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Antifungal Treatment Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Antifungal Treatment Sales Value
6.3 United States
6.3.1 United States Antifungal Treatment Sales Value, 2019-2030
6.3.2 United States Antifungal Treatment Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Antifungal Treatment Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Antifungal Treatment Sales Value, 2019-2030
6.4.2 Europe Antifungal Treatment Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Antifungal Treatment Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Antifungal Treatment Sales Value, 2019-2030
6.5.2 China Antifungal Treatment Sales Value by Type (%), 2023 VS 2030
6.5.3 China Antifungal Treatment Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Antifungal Treatment Sales Value, 2019-2030
6.6.2 Japan Antifungal Treatment Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Antifungal Treatment Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Antifungal Treatment Sales Value, 2019-2030
6.7.2 South Korea Antifungal Treatment Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Antifungal Treatment Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Antifungal Treatment Sales Value, 2019-2030
6.8.2 Southeast Asia Antifungal Treatment Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Antifungal Treatment Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Antifungal Treatment Sales Value, 2019-2030
6.9.2 India Antifungal Treatment Sales Value by Type (%), 2023 VS 2030
6.9.3 India Antifungal Treatment Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Novartis
7.1.1 Novartis Profile
7.1.2 Novartis Main Business
7.1.3 Novartis Antifungal Treatment Products, Services and Solutions
7.1.4 Novartis Antifungal Treatment Revenue (US$ Million) & (2019-2024)
7.1.5 Novartis Recent Developments
7.2 Pfizer
7.2.1 Pfizer Profile
7.2.2 Pfizer Main Business
7.2.3 Pfizer Antifungal Treatment Products, Services and Solutions
7.2.4 Pfizer Antifungal Treatment Revenue (US$ Million) & (2019-2024)
7.2.5 Pfizer Recent Developments
7.3 Sanofi-Aventis
7.3.1 Sanofi-Aventis Profile
7.3.2 Sanofi-Aventis Main Business
7.3.3 Sanofi-Aventis Antifungal Treatment Products, Services and Solutions
7.3.4 Sanofi-Aventis Antifungal Treatment Revenue (US$ Million) & (2019-2024)
7.3.5 Merck&Co Recent Developments
7.4 Merck&Co
7.4.1 Merck&Co Profile
7.4.2 Merck&Co Main Business
7.4.3 Merck&Co Antifungal Treatment Products, Services and Solutions
7.4.4 Merck&Co Antifungal Treatment Revenue (US$ Million) & (2019-2024)
7.4.5 Merck&Co Recent Developments
7.5 Enzon Pharmaceuticals
7.5.1 Enzon Pharmaceuticals Profile
7.5.2 Enzon Pharmaceuticals Main Business
7.5.3 Enzon Pharmaceuticals Antifungal Treatment Products, Services and Solutions
7.5.4 Enzon Pharmaceuticals Antifungal Treatment Revenue (US$ Million) & (2019-2024)
7.5.5 Enzon Pharmaceuticals Recent Developments
7.6 Bayer AG
7.6.1 Bayer AG Profile
7.6.2 Bayer AG Main Business
7.6.3 Bayer AG Antifungal Treatment Products, Services and Solutions
7.6.4 Bayer AG Antifungal Treatment Revenue (US$ Million) & (2019-2024)
7.6.5 Bayer AG Recent Developments
7.7 Astellas Pharma
7.7.1 Astellas Pharma Profile
7.7.2 Astellas Pharma Main Business
7.7.3 Astellas Pharma Antifungal Treatment Products, Services and Solutions
7.7.4 Astellas Pharma Antifungal Treatment Revenue (US$ Million) & (2019-2024)
7.7.5 Astellas Pharma Recent Developments
7.8 GlaxoSmithKline
7.8.1 GlaxoSmithKline Profile
7.8.2 GlaxoSmithKline Main Business
7.8.3 GlaxoSmithKline Antifungal Treatment Products, Services and Solutions
7.8.4 GlaxoSmithKline Antifungal Treatment Revenue (US$ Million) & (2019-2024)
7.8.5 GlaxoSmithKline Recent Developments
7.9 Abbott
7.9.1 Abbott Profile
7.9.2 Abbott Main Business
7.9.3 Abbott Antifungal Treatment Products, Services and Solutions
7.9.4 Abbott Antifungal Treatment Revenue (US$ Million) & (2019-2024)
7.9.5 Abbott Recent Developments
8 Industry Chain Analysis
8.1 Antifungal Treatment Industrial Chain
8.2 Antifungal Treatment Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Antifungal Treatment Sales Model
8.5.2 Sales Channel
8.5.3 Antifungal Treatment Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Antifungal Treatment Market Trends
    Table 2. Antifungal Treatment Market Drivers & Opportunity
    Table 3. Antifungal Treatment Market Challenges
    Table 4. Antifungal Treatment Market Restraints
    Table 5. Global Antifungal Treatment Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Antifungal Treatment Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies Antifungal Treatment Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies Antifungal Treatment Product Type
    Table 9. Key Companies Time to Begin Mass Production of Antifungal Treatment
    Table 10. Global Antifungal Treatment Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antifungal Treatment as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global Antifungal Treatment Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global Antifungal Treatment Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global Antifungal Treatment Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global Antifungal Treatment Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global Antifungal Treatment Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global Antifungal Treatment Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global Antifungal Treatment Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global Antifungal Treatment Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global Antifungal Treatment Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global Antifungal Treatment Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global Antifungal Treatment Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global Antifungal Treatment Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global Antifungal Treatment Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global Antifungal Treatment Sales Value by Region (2019-2024) & (%)
    Table 27. Global Antifungal Treatment Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions Antifungal Treatment Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions Antifungal Treatment Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions Antifungal Treatment Sales Value, (2025-2030) & (US$ Million)
    Table 31. Novartis Basic Information List
    Table 32. Novartis Description and Business Overview
    Table 33. Novartis Antifungal Treatment Products, Services and Solutions
    Table 34. Revenue (US$ Million) in Antifungal Treatment Business of Novartis (2019-2024)
    Table 35. Novartis Recent Developments
    Table 36. Pfizer Basic Information List
    Table 37. Pfizer Description and Business Overview
    Table 38. Pfizer Antifungal Treatment Products, Services and Solutions
    Table 39. Revenue (US$ Million) in Antifungal Treatment Business of Pfizer (2019-2024)
    Table 40. Pfizer Recent Developments
    Table 41. Sanofi-Aventis Basic Information List
    Table 42. Sanofi-Aventis Description and Business Overview
    Table 43. Sanofi-Aventis Antifungal Treatment Products, Services and Solutions
    Table 44. Revenue (US$ Million) in Antifungal Treatment Business of Sanofi-Aventis (2019-2024)
    Table 45. Sanofi-Aventis Recent Developments
    Table 46. Merck&Co Basic Information List
    Table 47. Merck&Co Description and Business Overview
    Table 48. Merck&Co Antifungal Treatment Products, Services and Solutions
    Table 49. Revenue (US$ Million) in Antifungal Treatment Business of Merck&Co (2019-2024)
    Table 50. Merck&Co Recent Developments
    Table 51. Enzon Pharmaceuticals Basic Information List
    Table 52. Enzon Pharmaceuticals Description and Business Overview
    Table 53. Enzon Pharmaceuticals Antifungal Treatment Products, Services and Solutions
    Table 54. Revenue (US$ Million) in Antifungal Treatment Business of Enzon Pharmaceuticals (2019-2024)
    Table 55. Enzon Pharmaceuticals Recent Developments
    Table 56. Bayer AG Basic Information List
    Table 57. Bayer AG Description and Business Overview
    Table 58. Bayer AG Antifungal Treatment Products, Services and Solutions
    Table 59. Revenue (US$ Million) in Antifungal Treatment Business of Bayer AG (2019-2024)
    Table 60. Bayer AG Recent Developments
    Table 61. Astellas Pharma Basic Information List
    Table 62. Astellas Pharma Description and Business Overview
    Table 63. Astellas Pharma Antifungal Treatment Products, Services and Solutions
    Table 64. Revenue (US$ Million) in Antifungal Treatment Business of Astellas Pharma (2019-2024)
    Table 65. Astellas Pharma Recent Developments
    Table 66. GlaxoSmithKline Basic Information List
    Table 67. GlaxoSmithKline Description and Business Overview
    Table 68. GlaxoSmithKline Antifungal Treatment Products, Services and Solutions
    Table 69. Revenue (US$ Million) in Antifungal Treatment Business of GlaxoSmithKline (2019-2024)
    Table 70. GlaxoSmithKline Recent Developments
    Table 71. Abbott Basic Information List
    Table 72. Abbott Description and Business Overview
    Table 73. Abbott Antifungal Treatment Products, Services and Solutions
    Table 74. Revenue (US$ Million) in Antifungal Treatment Business of Abbott (2019-2024)
    Table 75. Abbott Recent Developments
    Table 76. Key Raw Materials Lists
    Table 77. Raw Materials Key Suppliers Lists
    Table 78. Antifungal Treatment Downstream Customers
    Table 79. Antifungal Treatment Distributors List
    Table 80. Research Programs/Design for This Report
    Table 81. Key Data Information from Secondary Sources
    Table 82. Key Data Information from Primary Sources
    Table 83. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. Antifungal Treatment Product Picture
    Figure 2. Global Antifungal Treatment Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Antifungal Treatment Sales Value (2019-2030) & (US$ Million)
    Figure 4. Antifungal Treatment Report Years Considered
    Figure 5. Global Antifungal Treatment Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Antifungal Treatment Revenue in 2023
    Figure 7. Antifungal Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. Azoles Picture
    Figure 9. Echinocandins Picture
    Figure 10. Polyenes Picture
    Figure 11. Allyamines Picture
    Figure 12. Other Picture
    Figure 13. Global Antifungal Treatment Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 14. Global Antifungal Treatment Sales Value Market Share by Type, 2023 & 2030
    Figure 15. Product Picture of Dermatophytosis
    Figure 16. Product Picture of Aspergillosis
    Figure 17. Product Picture of Candidiasis
    Figure 18. Product Picture of Other
    Figure 19. Global Antifungal Treatment Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 20. Global Antifungal Treatment Sales Value Market Share by Application, 2023 & 2030
    Figure 21. North America Antifungal Treatment Sales Value (2019-2030) & (US$ Million)
    Figure 22. North America Antifungal Treatment Sales Value by Country (%), 2023 VS 2030
    Figure 23. Europe Antifungal Treatment Sales Value (2019-2030) & (US$ Million)
    Figure 24. Europe Antifungal Treatment Sales Value by Country (%), 2023 VS 2030
    Figure 25. Asia Pacific Antifungal Treatment Sales Value (2019-2030) & (US$ Million)
    Figure 26. Asia Pacific Antifungal Treatment Sales Value by Country (%), 2023 VS 2030
    Figure 27. South America Antifungal Treatment Sales Value (2019-2030) & (US$ Million)
    Figure 28. South America Antifungal Treatment Sales Value by Country (%), 2023 VS 2030
    Figure 29. Middle East & Africa Antifungal Treatment Sales Value (2019-2030) & (US$ Million)
    Figure 30. Middle East & Africa Antifungal Treatment Sales Value by Country (%), 2023 VS 2030
    Figure 31. Key Countries/Regions Antifungal Treatment Sales Value (%), (2019-2030)
    Figure 32. United States Antifungal Treatment Sales Value, (2019-2030) & (US$ Million)
    Figure 33. United States Antifungal Treatment Sales Value by Type (%), 2023 VS 2030
    Figure 34. United States Antifungal Treatment Sales Value by Application (%), 2023 VS 2030
    Figure 35. Europe Antifungal Treatment Sales Value, (2019-2030) & (US$ Million)
    Figure 36. Europe Antifungal Treatment Sales Value by Type (%), 2023 VS 2030
    Figure 37. Europe Antifungal Treatment Sales Value by Application (%), 2023 VS 2030
    Figure 38. China Antifungal Treatment Sales Value, (2019-2030) & (US$ Million)
    Figure 39. China Antifungal Treatment Sales Value by Type (%), 2023 VS 2030
    Figure 40. China Antifungal Treatment Sales Value by Application (%), 2023 VS 2030
    Figure 41. Japan Antifungal Treatment Sales Value, (2019-2030) & (US$ Million)
    Figure 42. Japan Antifungal Treatment Sales Value by Type (%), 2023 VS 2030
    Figure 43. Japan Antifungal Treatment Sales Value by Application (%), 2023 VS 2030
    Figure 44. South Korea Antifungal Treatment Sales Value, (2019-2030) & (US$ Million)
    Figure 45. South Korea Antifungal Treatment Sales Value by Type (%), 2023 VS 2030
    Figure 46. South Korea Antifungal Treatment Sales Value by Application (%), 2023 VS 2030
    Figure 47. Southeast Asia Antifungal Treatment Sales Value, (2019-2030) & (US$ Million)
    Figure 48. Southeast Asia Antifungal Treatment Sales Value by Type (%), 2023 VS 2030
    Figure 49. Southeast Asia Antifungal Treatment Sales Value by Application (%), 2023 VS 2030
    Figure 50. India Antifungal Treatment Sales Value, (2019-2030) & (US$ Million)
    Figure 51. India Antifungal Treatment Sales Value by Type (%), 2023 VS 2030
    Figure 52. India Antifungal Treatment Sales Value by Application (%), 2023 VS 2030
    Figure 53. Antifungal Treatment Industrial Chain
    Figure 54. Antifungal Treatment Manufacturing Cost Structure
    Figure 55. Channels of Distribution (Direct Sales, and Distribution)
    Figure 56. Bottom-up and Top-down Approaches for This Report
    Figure 57. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano String